As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the immuno-oncology industry, including Incyte (NASDAQ:INCY) and its peers. Over the ...
New findings from the phase 2 NeoCOAST-2 platform study (NCT05061550) offer encouraging data for novel neoadjuvant treatment strategies in patients with untreated, resectable stage IIa to IIIb ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Codetta Biosciences, the pioneer in digital spatial polymerase chain reaction (dsPCR) and digital spatial immuno polymerase chain reaction (dsiPCR), announced today ...
In the rapidly advancing field of immuno-oncology research, there has been increasing focus on the utility and optimization of cell humanized mice for translational research. Conventional murine ...
Compugen's innovative approach targets under-explored immune pathways like PVRIG and IL-18 binding protein, offering potential upside, despite current market skepticism. With $113.2 million in cash ...
Abstract: Serological tests play important roles in the fight against the Coronavirus Disease 2019 (COVID-19). The most commonly used methods, enzyme-linked immunosorbent assays (ELISA), provide ...
Lugano, Switzerland, 2 December 2024 – The ESMO Immuno-Oncology Congress 2024 will take place in Geneva, Switzerland, from December 11-13, with an option to attend virtually. Leading experts will ...
IRVINE, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp (OCX). (Nasdaq: OCX), a diagnostics technology company, announced the peer-reviewed publication of positive data related to its ...
If you’re immuno-comprised, you probably know it. So you pay attention when you hear the media bleating about the risks of West Nile and other mosquito-borne viruses that you need to be vigilant about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback